期刊文献+

乳腺包裹性乳头状癌与乳腺导管原位癌的超声鉴别

Ultrasound Differentiation of Encapsulated Papillary Carcinoma of the Breast from Ductal Carcinoma in Situ
暂未订购
导出
摘要 目的:探讨乳腺包裹性乳头状癌(encapsulated papillary carcinoma,EPC)与乳腺导管内原位癌(ductal carcinoma in situ,DCIS)的超声表现差异并进行鉴别诊断。方法:选取2018年1月~2024年5月在泉州市第一医院经病理学证实的32例EPC患者及179例DCIS患者的临床资料并进行统计分析,比较二者的超声表现差异。结果:纳入比较的EPC患者的年龄明显高于DCIS患者,临床检体上EPC的触诊阳性率也高于DCIS,在超声图像上,二者的形状、纵横比、边界及内部钙化灶表现对比均有统计学意义(P<0.05)。结论:EPC和DCIS在年龄及临床触诊查体上存在差异,结合二者超声表现上的形态、纵横比、边界及内部钙化灶等表现,对鉴别两者有一定参考意义。 Objective:To investigate the ultrasound performance difference of breast encapsulated papillary carcinoma(EPC)and ductal carcinoma in situ(DCIS)and make the differential diagnosis.Methods:Clinical data and color Doppler ultrasound images of 32 EPC patients and 179 DCIS patients from January 2018 to May 2024 in Quanzhou First Hospital were selected and analyzed for statistical analysis to compare the differences in their ultrasound findings.Results:The age of EPC patients was significantly higher than that of DCIS patients,and the positive rate of EPC on clinical examination was also higher than that of DCIS.In the ultrasound images,the shape,aspect ratio,boundary and internal calcification findings were statistically significant(P<0.05).Conclusion:EPC and DCIS are different in age and clinical palpation,it has a certain reference significance to identify both by combining the shape,aspect ratio,boundary and internal calcification of the two ultrasound manifestations.
作者 谢巧捷 苏立阳 XIE Qiao-jie;SU Li-yang(Quanzhou First Hospital Affiliated to Fujian Medical University,Fujian Quanzhou 362000)
出处 《中国医疗器械信息》 2025年第4期11-13,30,共4页 China Medical Device Information
关键词 乳腺包裹性乳头状癌 乳腺导管内原位癌 超声表现 鉴别诊断 encapsulated papillary carcinoma intraductal carcinoma in situ of the breast ultrasonic manifestation differential diagnosis
  • 相关文献

参考文献10

二级参考文献92

  • 1Collins L C,Carlo V P,Hwang H,魏兵(摘译),步宏(审校).乳腺囊内型乳头状癌[J].临床与实验病理学杂志,2006,22(5):586-586. 被引量:43
  • 2Lakhani SR,Ellis IO,Schnitt SJ,et al.WHO classification of tumors of the breast[M].Lyon:IARC Press,2012:6.
  • 3Tavassoli FA,Devilee P.World Health Organization classification of tumours.Pathology & genetics of tumors of the breast and female genital organs[M].Lyon:IARC Press,2003:10-112.
  • 4Rakha EA,Reis-Filho JS,Baehner F,et al.Breast cancer prognostic classification in the molecular era:the role of histological grade[J].Breast Cancer Res,2010,12 (4):207.
  • 5Goldhirsch A,Winer EP,Coates AS,et al.Personalizing the treatment of women with early breast cancer:highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013[J].Ann Oncol,2013,24(9):2206-2223.
  • 6Aleskandarany MA,Rakha EA,Macmillan RD,et al.MIB1/ Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups[J].Breast Cancer Res Treat,2011,127(3):591-599.
  • 7Abdel-Fatah TM,Powe DG,Ball G,et al.Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer[J].J Pathol,2010,222(4):388-399.
  • 8Mackay A,Weigelt B,Grigoriadis A,et al.Microarray-based class discovery for molecular classification of breast cancer:analysis of interobserver agreement[J].J Natl Cancer Inst,2011,103(8):662-673.
  • 9Parker JS,Mullins M,Cheang MC,et al.Supervised risk predictor of breast cancer based on intrinsic subtypes[J].J Clin Oncol,2009,27(8):1160-1167.
  • 10Choi J,Jung WH,Koo JS.Clinicopathologic features of molecular subtypes of triple negative breast cancer based on immunohistochemical markers[J].Histol Histopathol,2012,27(11):1481-1493.

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部